List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 267 studies with search of: "Neuroblastoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma
Conditions: Relapsed Neuroblastoma;   Refractory Neuroblastoma;   Relapsed Medulloblastoma;   Refractory Medulloblastoma
Intervention: Drug: TPI 287
2 Withdrawn High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: iodine I 131 metaiodobenzylguanidine;   Drug: topotecan hydrochloride;   Procedure: chemotherapy;   Procedure: peripheral blood stem cell transplantation;   Procedure: radioisotope therapy;   Procedure: radionuclide imaging;   Procedure: radiosensitization;   Procedure: total-body irradiation
3 Recruiting Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Temsirolimus;   Drug: Irinotecan;   Procedure: Surgical Resection of Primary Tumor;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Etoposide;   Drug: Cisplatin;   Drug: Topotecan;   Procedure: PBSC;   Radiation: Radiation Therapy;   Drug: 13-cis-retinoic acid
4 Completed Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: Interleukin-2
5 Recruiting A Phase I/Ii Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells After High-Dose Chemotherapy And Autologous Stem Cell Rescue In Patients With High Risk Neuroblastoma
Condition: Neuroblastoma
Intervention: Biological: SJNB-JF-IL2 and SJNB-JF-Lptn cells and SKNLP Unmodified Neuroblastoma Cell Lines
6 Active, not recruiting Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: melphalan;   Drug: tretinoin;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: autologous bone marrow transplantation;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
7 Recruiting Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: doxorubicin hydrochloride;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate
8 Active, not recruiting Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: gene-modified tumor cell vaccine therapy;   Biological: interleukin-2 gene
9 Active, not recruiting Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy
Condition: Neuroblastoma
Intervention: Biological: autologous neuroblastoma vaccine
10 Completed Gene Therapy in Treating Children With Relapsed or Refractory Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: aldesleukin;   Biological: gene-modified tumor cell vaccine therapy
11 Completed Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma
Condition: Neuroblastoma
Interventions: Procedure: Skin Biopsy;   Procedure: Injection of Gene Modified Neuroblastoma Cells
12 Active, not recruiting Multiple Therapies in Treating Patients With Advanced Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Biological: monoclonal antibody 3F8;   Biological: sargramostim;   Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: isotretinoin;   Drug: thiotepa;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Procedure: autologous bone marrow transplantation;   Procedure: bone marrow ablation with stem cell support;   Procedure: conventional surgery;   Procedure: drug resistance inhibition treatment;   Procedure: peripheral blood stem cell transplantation;   Procedure: syngeneic bone marrow transplantation;   Radiation: radiation therapy
13 Active, not recruiting Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: vincristine sulfate;   Procedure: conventional surgery
14 Recruiting XK469 in Treating Patients With Advanced Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: R(+)XK469
15 Active, not recruiting Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: monoclonal antibody 3F8;   Drug: etoposide;   Drug: isotretinoin
16 Recruiting Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: topotecan hydrochloride
17 Active, not recruiting Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
18 Recruiting Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: monoclonal antibody 3F8;   Biological: sargramostim
19 Completed Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: isotretinoin;   Drug: melphalan;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Procedure: autologous bone marrow transplantation;   Procedure: bone marrow ablation with stem cell support;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
20 Recruiting Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide phosphate;   Drug: ifosfamide;   Drug: isotretinoin;   Drug: melphalan;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Radiation: iobenguane I 131;   Radiation: radiation therapy

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services